|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Chlamydia IgG (Trachomatis) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Epstein-Barr Virus (EBNA-1) IgG ELISA | GIP (Active Form) ELISA Assay | Proinsulin (Intact) LUM Assay |
| Citations | | | | | |
| Catalog Number | IB19202 | TM09036 | IB79859 | 27201 | IV2-002 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the detection of IgG antibody to Chlamydia Trachomatis in human serum or plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay for the determination of IgG-class antibodies to Epstein-Barr virus nuclear antigen type 1 (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination active form human GIP in EDTA-plasma. For research use only, not for use in diagnostic procedures. | The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro diagnostics.... Read More |
| Detection Target | Chlamydia IgG (Trachomatis) | sAPP Total | SCC | Angiotensinogen Total | IGFBP-3 |
| Sample Type | Human serum or plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum | Serum, Blood Plasma, Urine, Cell Culture Media | Serum, Blood Plasma, Follicular Fluid, Seminal Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Luminescence (LUM) Assay |
| Detection Range | Cut-off value (calculated from the OD of the calibrator) used to interpret results of unknowns. | Anti-Ustekinumab (Stelara®) | A cut-off control is used for the interpretation of results. | 1.6 to 100 pg/mL | 1.5 to 110.0 pmol/L |
| Sensitivity | Inquire | 0.06 ng/mL | Inquire | 0.03 ng/mL | 0.5 ng/mL |
| Assay Time | 20 min.incubation (RT) + 20 min. (RT) + 10 min. (RT) + 50 min. total incubation time. | 2 hour, 30 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hr (incubation) | 3 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |